In the Glioma_GSE131928_Smartseq2 dataset, which contains 7,930 cells from 28 glioma patients, SLC1A5 was highly expressed in malignant cells and monocytes/macrophages in the glioma microenvironment (Figure 2C). This evidence concerns the gene SLC1A5 and central nervous system cancer.